Additionally, reduced PRB3 expression was associated with tumor recurrence, suggesting that low PRB3 mRNA levels may contribute to dopamine agonist resistance and tumor recurrence in prolactinomas (Wang et al., 2014). The gene discussed is PRB3; the disease is neoplasm.